How do phosphodiesterase 5 inhibitors (PDE5is) compare with endothelin receptor antagonists (ERAs) for adults with pulmonary artery hypertension?

Cochrane Clinical Answers ◽

10.1002/cca.2501 ◽

2019 ◽

Author(s):

Jane Burch ◽

Juliana Ester Martin

Keyword(s):

Pulmonary Artery ◽

Pulmonary Artery Hypertension ◽

Endothelin Receptor Antagonists ◽

Endothelin Receptor ◽

Receptor Antagonists ◽

Phosphodiesterase 5 Inhibitors ◽

Phosphodiesterase 5

Download Full-text

Substrate-specific pharmacokinetic interaction between endothelin receptor antagonists and phosphodiesterase-5 inhibitors - assembling the clues

British Journal of Clinical Pharmacology ◽

10.1111/j.1365-2125.2009.03374.x ◽

2009 ◽

Vol 67 (4) ◽

pp. 475-477 ◽

Cited By ~ 2

Author(s):

Nuggehally R. Srinivas

Keyword(s):

Pharmacokinetic Interaction ◽

Endothelin Receptor Antagonists ◽

Endothelin Receptor ◽

Receptor Antagonists ◽

Phosphodiesterase 5 Inhibitors ◽

Phosphodiesterase 5

Download Full-text

Effect of Phosphodiesterase-5 Inhibitors and Endothelin Receptor Antagonists on Change in Six-Minute Walk Distance in Patients With Moderate Pulmonary Hypertension

CHEST Journal ◽

10.1378/chest.1386301 ◽

2012 ◽

Vol 142 (4) ◽

pp. 827A ◽

Cited By ~ 2

Author(s):

Thiago Jabuonski ◽

Jeremy Mazurek ◽

Ronald Zolty

Keyword(s):

Pulmonary Hypertension ◽

Endothelin Receptor Antagonists ◽

Endothelin Receptor ◽

Receptor Antagonists ◽

Walk Distance ◽

Phosphodiesterase 5 Inhibitors ◽

Phosphodiesterase 5 ◽

Minute Walk Distance ◽

Minute Walk

Download Full-text

Comparison of the Effects of Continuous I.V. Epoprostenol Alone or in Combination with Endothelin Receptor Antagonists and Phosphodiesterase-5 Inhibitors.

10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a3372 ◽

2009 ◽

Author(s):

L Negro ◽

M Palazzini ◽

E Conficoni ◽

E Leci ◽

A Marinelli ◽

...

Keyword(s):

Endothelin Receptor Antagonists ◽

Endothelin Receptor ◽

Receptor Antagonists ◽

Phosphodiesterase 5 Inhibitors ◽

Phosphodiesterase 5

Download Full-text

Simultaneous quantification of endothelin receptor antagonists and phosphodiesterase 5 inhibitors currently used in pulmonary arterial hypertension

Journal of Pharmaceutical and Biomedical Analysis ◽

10.1016/j.jpba.2017.05.052 ◽

2017 ◽

Vol 143 ◽

pp. 291-298 ◽

Cited By ~ 8

Author(s):

Yeliz Enderle ◽

Lukas Witt ◽

Heinrike Wilkens ◽

Ekkehard Grünig ◽

Walter E. Haefeli ◽

...

Keyword(s):

Pulmonary Arterial Hypertension ◽

Arterial Hypertension ◽

Endothelin Receptor Antagonists ◽

Endothelin Receptor ◽

Receptor Antagonists ◽

Simultaneous Quantification ◽

Phosphodiesterase 5 Inhibitors ◽

Pulmonary Arterial ◽

Phosphodiesterase 5

Download Full-text

Endothelin in Health and Disease: Endothelin Receptor Antagonists in the Management of Pulmonary Artery Hypertension

Journal of Cardiovascular Pharmacology and Therapeutics ◽

10.1177/107424840200700i102 ◽

2002 ◽

Vol 7 (1) ◽

pp. 9-19 ◽

Cited By ~ 30

Author(s):

Nick H.S. Kim ◽

Lewis J. Rubin

Keyword(s):

Pulmonary Artery ◽

Pulmonary Artery Hypertension ◽

Endothelin Receptor Antagonists ◽

Endothelin Receptor ◽

Receptor Antagonists ◽

Health And Disease

Download Full-text

CLINICAL IMPROVEMENT IN PATIENTS WITH EXERCISE INDUCED PULMONARY ARTERY HYPERTENSION AFTER 6 MONTHS OF PHOSPHODIESTERASE-5 INHIBITORS OR ENDOTHELIAL RECEPTOR ANTAGONISTS OR BOTH

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(14)61663-6 ◽

2014 ◽

Vol 63 (12) ◽

pp. A1660

Author(s):

Santhosh R. Mannem ◽

Jason Salamon ◽

Sampath Gunda ◽

Muhammed Iqbal ◽

Manoj Bhandari ◽

...

Keyword(s):

Pulmonary Artery ◽

Clinical Improvement ◽

Pulmonary Artery Hypertension ◽

Receptor Antagonists ◽

Phosphodiesterase 5 Inhibitors ◽

Exercise Induced ◽

Endothelial Receptor ◽

Phosphodiesterase 5

Download Full-text

Endothelin receptor antagonists for the treatment of pulmonary artery hypertension

Life Sciences ◽

10.1016/j.lfs.2012.07.033 ◽

2012 ◽

Vol 91 (13-14) ◽

pp. 517-521 ◽

Cited By ~ 46

Author(s):

Lewis J. Rubin

Keyword(s):

Pulmonary Artery ◽

Pulmonary Artery Hypertension ◽

Endothelin Receptor Antagonists ◽

Endothelin Receptor ◽

Receptor Antagonists

Download Full-text

Role and Effect of Phosphodiesterase-5 Inhibitors and Endothelin Receptor Antagonists in the Treatment of Moderate Pulmonary Hypertension

Journal of Cardiac Failure ◽

10.1016/j.cardfail.2012.06.221 ◽

2012 ◽

Vol 18 (8) ◽

pp. S64

Author(s):

Thiago Jabuonski ◽

Jeremy A. Mazurek ◽

Ronald Zolty

Keyword(s):

Pulmonary Hypertension ◽

Endothelin Receptor Antagonists ◽

Endothelin Receptor ◽

Receptor Antagonists ◽

Phosphodiesterase 5 Inhibitors ◽

Phosphodiesterase 5

Download Full-text

What are the effects of phosphodiesterase 5 inhibitors (PDE5is) for people with pulmonary artery hypertension?

Cochrane Clinical Answers ◽

10.1002/cca.2454 ◽

2019 ◽

Author(s):

Jane Burch ◽

Juliana Ester Martin

Keyword(s):

Pulmonary Artery ◽

Pulmonary Artery Hypertension ◽

Phosphodiesterase 5 Inhibitors ◽

Phosphodiesterase 5

Download Full-text

Agonist-Dependent Inhibition by Peptide and Nonpeptide Endothelin Receptor Antagonists in the Rabbit Isolated Pulmonary Artery

Journal of Cardiovascular Pharmacology ◽

10.1097/00005344-199506263-00114 ◽

1995 ◽

Vol 26 ◽

pp. S385 ◽

Cited By ~ 3

Author(s):

George R. Beck ◽

Stephen A. Douglas ◽

John D. Elliott ◽

Eliot H. Ohlstein

Keyword(s):

Pulmonary Artery ◽

Endothelin Receptor Antagonists ◽

Endothelin Receptor ◽

Receptor Antagonists ◽

Dependent Inhibition ◽

Isolated Pulmonary Artery

Download Full-text